Antioxidant regulation of protein kinase C in cancer prevention

Journal of Nutrition

Volumn 132, Issue 12, 2002, Pages

  Gopalakrishna, Rayudu ^a   Gundimeda, Usha ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antioxidants; Cancer prevention; Protein kinase C; Selenium; Thioredoxin reductase

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 4 HYDROXYTAMOXIFEN; ANTIOXIDANT; CALPHOSTIN C; CHELERYTHRINE; CURCUMIN; ELLAGIC ACID; FATTY ACID; GLUTATHIONE PEROXIDASE; HYDROPEROXIDE; HYPERICIN; METHYLSELENINIC ACID; METHYLSELENOL; POLYPHENOL DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SCAVENGER; SELENITE; SELENIUM; SELENIUM DERIVATIVE; SELENOCYSTEINE; SELENOMETHIONINE; SELENOPROTEIN; STAUROSPORINE; THIOL DERIVATIVE; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG; ZINC;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CANCER RESISTANCE; CELL DEATH; CELL GROWTH; CLINICAL TRIAL; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; LUNG CARCINOMA; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; PRECANCER; PROSTATE CANCER; PROTEIN DOMAIN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TOXICITY; TUMOR PROMOTION;

EID: 0036901001     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.12.3819s     Document Type: Conference Paper

References (50)

1. Wattenberg, L. W. (1983) Inhibition of neoplasia by minor dietary constituents. Cancer Res. (Suppl) 43: 2448s-2455s.
2. Rogers, A. E. & Longnecker, M. P. (1988) Dietary and nutritional influences on cancer: A review of epidemiologic and experimental data. Lab. Invest. 59:729-759.
3. Krinsky, N. I. (1998) Overview of lycopene and carotenoids, disease prevention. Proc. Soc. Exp. Biol. Med. 218: 95-97.
4. Trush, M. A. & Kensler, T. W. (1991) An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10: 201-209.
5. Gopalakrishna, R. & Jaken, S. (2000) Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28: 1349-1361.
6. Azzi, A., Breyer, I., Feher, M., Ricciarelli, R., Stocker, A., Zimmer, S. & Zingg, J.-M. (2001) Nonantioxidant functions of α-tocopherol in smooth muscle cells. J. Nutr. 131: 378S-381S.
7. Sen, C. K., Khanna, S., Roy, S. & Packer, L. (2000) Molecular basis of vitamin E action. Tocotrienols potently inhibit glutamate-induced pp60 c-src kinase activation of HT4 neuronla cells. J. Biol. Chem. 275: 13049-13055.
8. Kim, Y. S. & Milner, J. (2001) Molecular targets for selenium in cancer prevention. Nutr. Cancer 40: 50-54.
9. Gopalakrishna, R. & Gundimeda, U. (2001) Protein kinase C as a molecular target for cancer prevention by selenocompounds. Nutr. Cancer 40: 55-63.
10. Zi, X., Grasso, A. W., Kung, H. J. & Agarwal, R. (1998) A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res. 58: 1920-1929.
11. Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington, DC) 258: 607-614.
12. Stauble, B., Boscoboinik, D., Tasinato, A. & Azzi, A. (1994) Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and α-tocopherol in vascular smooth muscle cells. Eur. J. Biochem. 226: 393-402.
13. Amstad, P. A., Krupitza, G. & Cerutti, P. A. (1992) Mechanism of c-fos induction by active oxygen. Cancer Res. 52: 3952-3960.
14. +-, and phospholipid-independent activation of protein kinase C by selective oxidative modification of regulatory domain. Proc. Natl. Acad. Sci. U.S.A. 86: 6758-6762.
15. Gopalakrishna, R. & Anderson, W. B. (1991) Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys. 285: 382-387.
16. Gopalakrishna, R., Chen, Z. H. & Gundimeda, U. (1994) Tobacco smoke tumor promoters, catechol and hydroquinone induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 91: 12233-12237.
17. Gopalakrishna, R., Chen, Z. H. & Gundimeda, U. (1995) Modification of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and the enzyme specific inhibitors. Methods Enzymol. 252: 134-148.
18. Kazanietz, M. G., Wang, S., Milner, G. W. A., Lewin, N. E., Liu, H. L. & Blumberg, P. M. (1995) Residues in the second cysteine-rich region of protein kinase C relevant to phorbol ester binding as revealed by site-directed mutagenesis. J. Biol. Chem. 270: 21852-21859.
19. Gundimeda, U., Chen, Z. & Gopalakrishna, R. (1996) Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J. Biol. Chem. 271: 13504-13514.
20. Chen, Z., Gundimeda, U. & Gopalakrishna, R. (1996) Curcumin irreversibly inactivates protein kinase C activity and phorbol ester binding: Its possible role in cancer chemoprevention. Proc. Am. Assoc. Cancer Res. 37: 282 (abs.).
21. Chen, Z., Gundimeda, U. & Gopalakrishna, R. (1997) Ellagic acid induces oxidative inactivation of protein kinase C by modifying both catalytic and regulatory domain. Proc. Am. Assoc. Cancer Res. 36: 586 (abs.).
22. Gopalakrishna, R., Gundimeda, U. & Chen, Z. (1995) Vitamin E succinate inhibits protein kinase C: Correlation with its unique inhibitory effects on cell growth and transformation. In: Nutrients and Cancer (Prasad, K. N. et al., eds.), pp. 21-37. Humana Press, Totowa, NJ.
23. 2+-dependent isoenzymes of protein kinase C. Arch. Biochem. Biophys. 348: 25-36.
24. Ip, C. & Ganther, H. E. (1990) Activity of methylated forms of selenium in cancer prevention. Cancer Res. 50: 1206-1211.
25. Ganther, H. E. (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis 20: 1657-1666.
26. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R. & Coltman, C. (2001) Select: The next prostate cancer prevention trial. J. Urol. 166: 13311-1315.
27. Combs, G. F., Jr. & Gray, W. P. (1998) Chemopreventive agent: Selenium. Pharmacol. Ther. 79: 179-192.
28. Greeder, G. A. & Milner, J. A. (1980) Factors influencing the inhibitory effect of selenium on mice inoculated with Erlich ascites tumor cells. Science (Washington, DC) 209: 825-826.
29. Pence, B. C., Delver, E. & Dunn, D. M. (1994) Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J. Invest. Dermatol. 102: 759-761.
30. Clark, L. C., Combs, G. F., Tumbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L, Jr., Park, H. K., Sanders, B. B., Jr., Smith, C. L. & Taylor, J. R. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. J. Am. Med. Assoc. 276: 1957-1963.
31. 14C] phenylenebis-(methylene)selenocyanate in the rat. Carcinogenesis 19: 1603-1607.
32. Medina, D. & Oborn, C. J. (1984) Selenium inhibition of DNA Synthesis in mouse mammary epithelial cell line YN-4. Cancer Res. 44: 4361-4365.
33. Redman, C., Scot, J. A., Bainec, A. T., Basye, J. L., Clark, L. C., Calley, C., Roe, D., Payne, C. M. & Nelson, M. A. (1998) Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett. 125: 103-110.
34. Whanger, P., Vendeland, S., Park, Y. C. & Xia, Y. (1996) Metabolism of subtoxic levels of selenium in animals and humans. Ann. Clin. Lab. Sci. 26: 99-113.
35. O'Brian, C. A., Ward, N. E., Weinstein, I. B., Bull, A. W. & Marnett, L. J. (1988) Activation of rat brain protein kinase C by lipid oxidation products. Biochem. Biophys. Res. Commun. 155: 1374-1380.
36. Gopalakrishna, R. & Gundimeda, U. (2000) Selenoprotein thioredoxin reductase activates the oxidized protein kinase C by a direct interaction with its zinc-thiolates. FASEB J. 14: A296.
37. Gorlatov, S. M. & Stadtman, T. C. (1998) Human thioredoxin reductase from HeLa cells: Selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc. Natl. Acad. Sci. U.S.A. 95: 8520-8525.
38. Spallholz, J. E. (1994) On the nature of selenium toxicity and carcinostatic activity. Free Radic. Biol. Med. 17: 45-64.
39. Gopalakrishna, R., Chen, Z. H. & Gundimeda, U. (1997) Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: Its role in inhibition of tumor promotion. Arch. Biochem. Biophys. 348: 37-48.
40. O'Brien, T. G., Megosh, L. C., Gilliard, G. & Soler, A. P. (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57: 2630-2637.
41. Sinha, R., Kiley, S. C, Lu, J. X., Thompson, J. J., Moraes, R., Jaken, S. & Medina, D. (1999) Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett. 146: 135-145.
42. Lu, J., Kaeck, M., Jiang, C., Wilson, A. C. & Thompson, H. J. (1994) Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem. Pharmacol. 47: 1531-1535.
43. Jarvis, W. D., Turner, A. J., Povirk, L. F., Taylor, R. S. & Grant, S. (1994) Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54: 1707-1714.
44. Haimovitz-Friedman, A., Kolesnick, R. N. & Fuks, Z. (1997) Ceramide signaling in apoptosis. Br. Med. Bull. 53: 539-553.
45. Gopalakrishna, R. & Gundimeda, U. (2000) Selenium-induced apoptosis in prostate cancer cells: Role of protein kinase C inactivation and ceramide generation. Proc. Am. Assoc. Cancer. Res. 41: 341 (abs.).
46. Bradham, C., Quian, T., Streetz, K., Trautwein, C., Brenner, D. A. & Lemasters, J. J. (1998) The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 6353-6364.
47. Ruvolo, P. P., Deng, X., Carr, B. K. & May, W. S. A. (1998) Functional role for mitochondrial protein kinase C in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273: 25436-25422.
48. Kluck, R. M., Bossy-Wetzel, E., Green, D. R. & Newmeyer, D. D. (1997) The release of cytochrome C from mitochondria. A primary site of Bcl-2 regulation of apoptosis. Science (Washington, DC) 275: 1132-1136.
49. Denning, M. F., Wang, Y., Nickoloff, B. J. & Wrone-Smith, T. (1998) Protein kinase Cδ is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem. 273: 29995-30002.
50. Hartley, J. A., Gibson, N. W., Kilkenny, A. & Yuspa, S. H. (1987) Mouse keratinocytes derived from initiated skin or papillomas are resistant to DNA strand breakage by benzoyl peroxide: A possible mechanism for tumor promotion mediated by benzoyl peroxide. Carcinogenesis 8: 1827-1830.